Functionally, cDC1s are uniquely equipped for cross‐presentation of exogenous antigens on MHCI molecules and play a nonredundant role in activating cytotoxic CD8+ T lymphocytes (CTLs), particularly in the context of viral infections and cancer [13, 14]. Here, CD8A is linked to cancer.